RapidPulse closes US$15 million Series A financing

KUALA LUMPUR, June 24 -- RapidPulse Inc, a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, has announced the closing of a US$15 million Series A financing. (US$1 = RM4.162) The financing was led by Santé Ventures who was joined by Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon. According to a statement, RapidPulse plans to use the proceeds to advance its RapidPulse™ Cyclic Aspiration System through expanded clinical evaluation and build out its platform of proprietary catheters. The RapidPulse™ system was developed by Syntheon, a medical device incubator focused on developing next generation medical devices. “We are pleased to have partnered with an outstanding investor syndicate to move our RapidPulse™ technology forward in the clinic,” said Chief Executive Officer (CEO) of Syntheon, Sean McBrayer, who will also serve as initial CEO of RapidPulse. “Stroke is the second leading cause of death and the third leading cause of disability worldwide, and minutes matter in improving these outcomes. This investment will help us expand our clinical results and move towards regulatory approval in the United States.” Joining the team are industry veterans Heather Harries and Cynthia Yang. Harries most recently served as General Manager for Terumo’s aortic business and will lead product development and operations for RapidPulse, while Yang will lead clinical development for the company, after most recently working in the neurovascular division of Medtronic. More details at www.rapidpulsemed.com. -- BERNAMA